Favipiravir is used in patients with mild to moderate Covid-19 infection because it inhibits and stops viral protein synthesis and induces fatal metagenesis of the influenza virus.
BALflu is a broad spectrum formulation that can also be used in the treatment of 53 types of influenza viruses, including seasonal strains such as Ebola virus, arenavirus, bunyavirus, filovirus, West Nile virus and lassa virus, Bal Pharma said in a regulatory filing.
The company’s product is approved by the Drug Controller General of India (DCGI) for emergency use for the treatment of Covid-19 with a recommended dosage of 1800 mg on the first day, followed by 800 mg on day 2 through day 14, he added.
Bal Pharma, Managing Director Shailesh Siroya, said that BALflu has the effectiveness of clearing the virus faster by 28.7% and is marketed at a very affordable price of Rs 85 per pill to enable patients in need of ‘access this medication on time.
BALflu is available in all major markets in India as a prescription drug, he added.